NASDAQ : MRSN

Mersana Therapeutics, Inc.

$29.08 USD

$0 (0.0%)

Volume
624.02K
Average Volume
135.97K
Market Capitalization
$145.36M
P/E Ratio
-2.59
Dividend Yield
0.00%
Price Target
$10.00
Year High
$30.39
Year Low
$5.21
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.39
Source Headline

Get MRSN Insider Trade Alerts

MRSN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$17.00

1 analysts

All Time

$10.00

2 analysts

MRSN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-11-14 Guggenheim Downgrade Buy Neutral
2025-11-13 Truist Securities Downgrade Buy Hold
2025-11-13 BTIG Downgrade Buy Neutral
2025-08-14 Guggenheim Maintain Buy Buy
2025-08-14 Truist Securities Maintain Buy Buy
2025-05-16 Guggenheim Maintain Buy Buy
2025-05-16 Truist Securities Maintain Buy Buy
2024-08-27 Citigroup Maintain Buy Buy
2024-08-14 Baird Maintain Neutral Neutral
2024-03-19 JP Morgan Upgrade Underweight Neutral
2024-02-29 Truist Securities Upgrade Hold Buy
2024-02-29 Guggenheim Upgrade Neutral Buy
2024-02-29 Wedbush Upgrade Neutral Outperform
2024-02-29 Baird Maintain Neutral Neutral
2023-12-04 Citigroup Upgrade Neutral Buy
2023-08-07 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-07 HC Wainwright & Co. Maintain Buy Buy
2023-08-07 Credit Suisse Maintain Outperform Outperform
2023-07-30 HC Wainwright & Co. Maintain Buy Buy
2023-07-28 Citigroup Downgrade Buy Neutral
2023-07-28 Baird Downgrade Outperform Neutral
2023-07-27 Truist Securities Downgrade Buy Hold
2023-07-27 Wedbush Downgrade Outperform Neutral
2023-06-25 Needham Maintain Buy Buy
2023-06-16 JP Morgan Downgrade Overweight Neutral
2023-06-16 Citigroup Maintain Buy Buy
2023-06-07 HC Wainwright & Co. Maintain Buy Buy
2023-05-22 Cantor Fitzgerald Maintain Overweight Overweight
2023-05-11 Citigroup Maintain Buy Buy
2023-05-05 Credit Suisse Maintain Outperform Outperform
2023-05-05 Needham Maintain Buy Buy
2023-05-05 HC Wainwright & Co. Maintain Buy Buy
2023-04-30 B of A Securities Upgrade Underperform Neutral
2023-03-16 JP Morgan Upgrade Neutral Overweight
2023-03-16 Needham Maintain Buy Buy
2023-03-07 Needham Maintain Buy Buy
2023-03-07 Cantor Fitzgerald Maintain Overweight Overweight
2023-03-06 Wedbush Maintain Outperform Outperform
2023-03-06 Credit Suisse Maintain Outperform Outperform
2023-01-10 Credit Suisse Maintain Outperform Outperform
2022-12-04 HC Wainwright & Co. Maintain Buy Buy
2022-11-21 Truist Securities Maintain Buy Buy
2022-11-14 Credit Suisse Maintain Outperform Outperform
2022-11-13 Needham Maintain Buy Buy
2022-08-09 SVB Leerink Maintain Outperform Outperform
2022-08-09 Baird Maintain Outperform Outperform
2022-08-07 Needham Maintain Buy Buy
2022-05-25 Cantor Fitzgerald Maintain Overweight Overweight
2022-05-09 SVB Leerink Maintain Outperform Outperform
2022-03-15 B of A Securities Maintain Buy Buy
2022-02-18 SVB Leerink Maintain Outperform Outperform
2021-11-21 JP Morgan Upgrade Neutral Overweight
2021-08-30 HC Wainwright & Co. Maintain Buy Buy
2021-05-18 UBS Maintain Neutral Neutral
2021-05-09 Wedbush Upgrade Neutral Outperform
2021-03-31 Credit Suisse Maintain Neutral Neutral
2021-03-10 Canaccord Genuity Maintain Buy Buy
2021-03-09 Credit Suisse Maintain Outperform Outperform
2021-02-09 Wedbush Downgrade Outperform Neutral
2021-01-13 Needham Maintain Buy Buy
2020-12-27 Canaccord Genuity Maintain Buy Buy
2020-12-10 Needham Maintain Buy Buy
2020-12-03 Stifel Maintain Buy Buy
2020-11-12 Credit Suisse Maintain Outperform Outperform
2020-11-12 Canaccord Genuity Maintain Buy Buy
2020-11-09 SVB Leerink Maintain Outperform Outperform
2020-05-28 Baird Maintain Outperform Outperform
2020-05-27 H.C. Wainwright Maintain Buy Buy
2020-05-27 SVB Leerink Maintain Outperform Outperform
2020-04-29 BTIG Maintain Buy Buy
2019-12-18 Wedbush Maintain Outperform Outperform
2019-12-02 JP Morgan Maintain Overweight Overweight
2019-11-12 BTIG Maintain Neutral Neutral
2019-10-25 H.C. Wainwright Maintain Buy Buy
2019-07-15 JP Morgan Maintain Overweight Overweight
2019-07-15 Canaccord Genuity Maintain Buy Buy
2019-07-15 Cowen & Co. Maintain Outperform Outperform
2019-07-15 Credit Suisse Maintain Outperform Outperform
2019-03-11 JP Morgan Downgrade Neutral Underweight
2018-07-20 Leerink Swann Downgrade Overweight Market Perform
2018-05-08 Baird Maintain Outperform Outperform
2018-03-19 JP Morgan Downgrade Overweight Neutral
2018-03-19 JP Morgan Maintain Neutral Neutral
2018-02-15 H.C. Wainwright Maintain Buy Buy
2017-07-24 Leerink Swann Maintain Overweight Overweight
2017-07-24 Wedbush Maintain Outperform Outperform
2017-07-24 Cowen & Co. Maintain Outperform Outperform
2017-07-24 JP Morgan Maintain Overweight Overweight